Often, the most vulnerable population groups experience severe or even lethal forms of vaccine-preventable diseases, as well as losses in quality of life, functional ability and productivity. It is essential to identify these groups and their specific vaccination needs, and to take measures to improve vaccine confidence and uptake among them. Pharmacists play a key role in raising awareness and building confidence in vaccines, and in promoting a convenient access to vaccinations. Over several months, FIP organised a series of events focusing on the vaccination needs of several special-risk population groups. With this final event, we invite you to engage with an intersectoral roundtable on this topic and witness the launch of a summary publication and a series of short videos to support pharmacists in these roles.

By the end of the session participants will:
- Understand the specific vaccination needs of several special-risk population groups
- Become familiar with FIP’s resources on vaccination for special-risk groups
- Discuss the role of pharmacists in promoting vaccination uptake among different special-risk groups

Moderator:
- Catherine Duggan, FIP Chief Executive Officer, UK/Netherlands

Panellists:
- Jean-Luc Eiselé, CEO World Heart Federation, Switzerland
- Siân Williams, Chief Executive Officer International Primary Care Respiratory Group (IPCRG), Scotland (working internationally)
- Iryna Vlasenko, Vice president- International Diabetes Federation-Ukraine
- Howard Catton, Chief Executive Officer, International Council of Nurses, Switzerland/ United Kingdom
- Jane Barratt, Secretary-General International Federation on Ageing, Canada
- Rúben Viegas, FIP Practice Development and Transformation Projects Coordinator, Portugal
- Mary Ann Lumsden, FIGO Chief Executive, International Federation of Gynecology and Obstetrics (FIGO), UK

Pharmacists as athlete support personnel have rooted themselves as key players in medical teams serving athletes. Sports pharmacy evolved from a niche practice during the establishment of WADA two decades ago, gaining traction with the publication of the FIP guidelines “The Role of the Pharmacist in the Fight against Doping in Sport” in 2014. Today, we recognise sports pharmacy as a specialty practice, fundamental to the antidoping movement and athlete health. Pharmacists provide accurate sports drug information, avoid inadvertent doping, and coordinate pharmacy services at sporting events. We present two successful models in education and proper training of pharmacists to work with athletes.

Attendees will learn about:

1. Exploring the specialty of sports pharmacy based on expert consensus
2. Discussing a foundation for sports pharmacy curricula
3. Describing a successful example of sports pharmacy practice

Moderator:
- Daragh Connolly, Chair Board of Pharmaceutical Practice, Ireland

Panellists:
- Ashley Anderson, Clinical Sports Pharmacy Specialist / Antidoping Pharmacist International Sports Pharmacists Network, USA
- David Mottram, Emeritus Professor- Liverpool John Moores University, UK
- Mark Stuart, Pharmacist to the International Olympic Committee Medical Commission International Olympic Committee, UK
- Claire May, Academic University of Brighton, UK
- Somer Helvaci, Lecturer IOC accredited sports pharmacist, Turkey
- Shigeo Yamamura, Specially-Appointed Professor Josai International University, Japan

This event will assess the impact the COVID-19 pandemic has had on pharmaceutical education and also showcase educational approaches that were put in place in response to the pandemic, in particular noting how engagement was provided to learners. It will also consider how this learning is currently applied in pharmaceutical education and can be used to prepare for future pandemics.


Aim
To consider the current position of pharmaceutical education globally, the impact the COVID-19 pandemic has had on current education and how to prepare for future pandemics.

Learning objectives:

1. Describe how pharmaceutical education has changed over the COVID-19 pandemic;
2. Explain how different nations have co-ordinated pharmaceutical education during the pandemic;
3. List enablers and barriers to delivering innovative and high-quality education during a pandemic;
4. Discuss approaches needed to be taken in future pandemics to ensure pharmaceutical educational outcomes are delivered.

Moderators:
-Anisha Sandhu, Assistant Lecturer Monash University Malaysia, School of Pharmacy-Malaysia
-Desak Ernawati, Senior Lecturer Faculty of Medicine, Udayana University-Indonesia

Panellists:
-Ally Dering-Anderson, Clinical Associate Professor in the Department of Pharmacy Practice & Science University of Nebraska College of Pharmacy-USA
-Shepard Mhlaba, Drug Information Pharmacist/Research Assistant, Drug and Toxicology Information Services (DATIS), Harare-Zimbabwe
-Dalal Altaweel, Vice dean of Academic and Student affairs College of pharmacy, Kuwait university-Kuwait
-Shaun Gleason, Assistant Dean for Distance Degrees and Programs; Associate Professor of Clinical Pharmacy University of Colorado Skaggs School of Pharmacy -USA

One year after the launch of the FIP global call to action on advancing pharmaceutical education, FIP will report on each region’s progress against the call to action, building on the results of the FIP-UNITWIN inter-regional impact workshops held in November 2022. The event will also host the launch of the FIP Education transformation toolkit, which will be a collection of FIP’s relevant publications and digital events to implement the FIP global call to action on advancing pharmaceutical education.

Objectives:
1. Present progress since 2021 on priority FIP Development Goals of the regions in the context of pharmaceutical education
2. Present progress on FIP-UNITWIN regional roadmaps 2021 and the impact on FIP global call to action on pharmaceutical education
3. Discuss the way forward for the delivery of each regions’ roadmaps with establishment of regional FIP-UNITWIN centres for excellence programme in the months ahead
4. Launch the FIP Education transformation toolkit

Moderators:
- Ralph J. Altiere, FIPEd Chair FIP and University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences- USA
- Lilian Azzopardi, FIP AIM Chair-elect , University of Malta -Malta

Guests:
- Dominique Jordan, FIP President, Switzerland
- Catherine Duggan, FIP CEO, UK

Panellists:
- Toyin Tofade, President Albany College of Pharmacy and Health Sciences, USA
- Silvana Nair Leite, Professor Federal University of Santa Catarina, Brazil
- Arinola Joda, Assistant Secretary & Editor-in- Chief, African Pharmaceutical Forum, Faculty of Pharmacy, University of Lagos, Nigeria
- Rajani Shakya, Ass.Prof. Department of Pharmacy, Kathmandu University, Nepal
- Mohamad Rahal, Dean School of Pharmacy, Lebanese International University, Lebanon
- Paul Gallagher, Prof.Department of Pharmacy, National University of Singapore, Singapure
- Nilhan Uzman, FIP Lead for Education & Primary Health Policies, Turkey
- Alison Etukakpan, Educational Partnership Specialist International Pharmaceutical Federation, Nigeria